CHST3 ‐related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum
American Journal of Medical Genetics Part A · 2023-08 · 191 (8) · 2100-2112
DOI: 10.1002/ajmg.a.63246 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 14.05.2023. Verfasst von Ghada A Otaify und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt. Hauptthemen laut MEDLINE: Dwarfism, Osteochondrodysplasias. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Science and Technology Development Fund.
Abstract (Originalsprache)
Biallelic variants in CHST3 gene result in congenital dislocation of large joints, club feet, short stature, rhizomelia, kypho‐scoliosis, platyspondyly, epiphyseal dysplasia, flared metaphysis, in addition to minor cardiac lesions and hearing loss. Herein, we describe 14 new patients from 11 unrelated Egyptian families with CHST3 ‐related skeletal dysplasia. All patients had spondyloepiphyseal changes that were progressive with age in addition to bifid distal ends of humeri which can be considered a diagnostic key in patients with CHST3 variants. They also shared peculiar facies with broad forehead, broad nasal tip, long philtrum and short neck. Rare unusual associated findings included microdontia, teeth spacing, delayed eruption, prominent angulation of the lumbar‐sacral junction and atrial septal defect. Mutational analysis revealed 10 different homozygous CHST3 (NM_004273.5) variants including 7 missense, two frameshift and one nonsense variant. Of them, the c.384_391dup (p.Pro131Argfs*88) was recurrent in two families. Eight of these variants were not described before. Our study presents the largest series of patients with CHST3 ‐related skeletal dysplasia from the same ethnic group. Furthermore, it reinforces that lethal cardiac involvement is a critical clinical finding of the disorder. Therefore, we believe that our study expands the phenotypic and mutational spectrum, and also highlights the importance of performing echocardiography in patients harboring CHST3 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
- Medical Molecular Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
- Orodental Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
ORCID-Profile: Ghada A Otaify, Rasha M Elhossini, Inas M Sayed, Mohamed S Abdel-Hamid
Förderung
- Science and Technology Development Fund
Zitieren
APA
Otaify, G. A., Elhossini, R. M., Abdel-Ghafar, S. F., Sayed, I. M., Abdel-Salam, G. M. H., Aglan, M. S., & Abdel-Hamid, M. S. (2023). CHST3 ‐related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum. American Journal of Medical Genetics Part A, 191(8), 2100-2112. https://doi.org/10.1002/ajmg.a.63246
Vancouver
Otaify GA, Elhossini RM, Abdel-Ghafar SF, Sayed IM, Abdel-Salam GMH, Aglan MS, et al. CHST3 ‐related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum. American Journal of Medical Genetics Part A. 2023;191(8):2100-2112. doi:10.1002/ajmg.a.63246
BibTeX
@article{Otaify2023,
author = {Otaify, Ghada A and Elhossini, Rasha M and Abdel-Ghafar, Sherif F and Sayed, Inas M and Abdel-Salam, Ghada M H and Aglan, Mona S and Abdel-Hamid, Mohamed S},
title = {CHST3 ‐related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
volume = {191},
number = {8},
pages = {2100--2112},
doi = {10.1002/ajmg.a.63246}
}
EUVIMED